Researchers in University College Dublin (UCD) have discovered that a mutation in a gene called emc1 causes major vision problems in zebrafish.
Boehringer Ingelheim once again turns to RNAi for new MASH therapies
Boehringer Ingelheim is partnering with China-based biotech Suzhou Ribo Life Science and its Sweden-based unit Ribocure Pharmaceuticals to develop siRNA therapies for metabolic dysfunction-associated steatohepatitis